SI-BONE Statistics
Total Valuation
SI-BONE has a market cap or net worth of $684.41 million. The enterprise value is $565.32 million.
| Market Cap | 684.41M |
| Enterprise Value | 565.32M |
Important Dates
The next confirmed earnings date is Monday, August 5, 2024, after market close.
| Earnings Date | Aug 5, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
SI-BONE has 41.20 million shares outstanding. The number of shares has increased by 17.24% in one year.
| Shares Outstanding | 41.20M |
| Shares Change (YoY) | +17.24% |
| Shares Change (QoQ) | +0.82% |
| Owned by Insiders (%) | 2.14% |
| Owned by Institutions (%) | 101.04% |
| Float | 36.96M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.75 |
| Forward PS | 3.89 |
| PB Ratio | 4.13 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3.92 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.76, with a Debt / Equity ratio of 0.23.
| Current Ratio | 9.76 |
| Quick Ratio | 8.63 |
| Debt / Equity | 0.23 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -11.30 |
Financial Efficiency
Return on equity (ROE) is -25.10% and return on invested capital (ROIC) is -23.34%.
| Return on Equity (ROE) | -25.10% |
| Return on Assets (ROA) | -18.80% |
| Return on Capital (ROIC) | -23.34% |
| Revenue Per Employee | $418,735 |
| Profits Per Employee | -$125,334 |
| Employee Count | 344 |
| Asset Turnover | 0.63 |
| Inventory Turnover | 1.62 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -35.04% in the last 52 weeks. The beta is 1.20, so SI-BONE's price volatility has been higher than the market average.
| Beta (5Y) | 1.20 |
| 52-Week Price Change | -35.04% |
| 50-Day Moving Average | 13.90 |
| 200-Day Moving Average | 16.99 |
| Relative Strength Index (RSI) | 74.38 |
| Average Volume (20 Days) | 402,967 |
Short Selling Information
The latest short interest is 2.30 million, so 5.58% of the outstanding shares have been sold short.
| Short Interest | 2.30M |
| Short Previous Month | 2.41M |
| Short % of Shares Out | 5.58% |
| Short % of Float | 6.22% |
| Short Ratio (days to cover) | 6.79 |
Income Statement
In the last 12 months, SI-BONE had revenue of $144.05 million and -$43.12 million in losses. Loss per share was -$1.09.
| Revenue | 144.05M |
| Gross Profit | 112.50M |
| Operating Income | -47.68M |
| Pretax Income | -43.12M |
| Net Income | -43.12M |
| EBITDA | -34.18M |
| EBIT | -39.61M |
| Loss Per Share | -$1.09 |
Balance Sheet
The company has $157.82 million in cash and $38.73 million in debt, giving a net cash position of $119.09 million or $2.89 per share.
| Cash & Cash Equivalents | 157.82M |
| Total Debt | 38.73M |
| Net Cash | 119.09M |
| Net Cash Per Share | $2.89 |
| Equity (Book Value) | 165.54M |
| Book Value Per Share | 4.02 |
| Working Capital | 182.77M |
Cash Flow
In the last 12 months, operating cash flow was -$15.53 million and capital expenditures -$7.30 million, giving a free cash flow of -$22.83 million.
| Operating Cash Flow | -15.53M |
| Capital Expenditures | -7.30M |
| Free Cash Flow | -22.83M |
| FCF Per Share | -$0.56 |
Margins
Gross margin is 78.10%, with operating and profit margins of -33.10% and -29.93%.
| Gross Margin | 78.10% |
| Operating Margin | -33.10% |
| Pretax Margin | -29.93% |
| Profit Margin | -29.93% |
| EBITDA Margin | -23.73% |
| EBIT Margin | -27.50% |
| FCF Margin | -15.85% |
Dividends & Yields
SI-BONE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -17.24% |
| Shareholder Yield | -17.24% |
| Earnings Yield | -6.30% |
| FCF Yield | -3.34% |
Analyst Forecast
The average price target for SI-BONE is $25.71, which is 54.79% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $25.71 |
| Price Target Difference | 54.79% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SI-BONE has an Altman Z-Score of 5.52 and a Piotroski F-Score of 3.
| Altman Z-Score | 5.52 |
| Piotroski F-Score | 3 |